LY353381

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY353381, covering 2006-07-19 to 2017-05-30. Get the full timeline:

Most recent: Clinical Trial Update: LY353381 in Preventing Breast Cancer in Women With Hyperplasia [Phase 2]